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Background: The present study investigated associations between the strongest joint genetic risk
variants for bipolar disorder (BD) and schizophrenia (SCZ) and a history of suicide attempt in patients
with BD, SCZ and related psychiatric disorders.
Methods: A history of suicide attempt was assessed in a sample of 1009 patients with BD, SCZ and related
psychosis spectrum disorders, and associations with the joint genetic risk variants for BD and SCZ
(rs2239547 (ITIH3/4-region), rs10994359 (ANK3) and rs4765905 (CACNA1C)) were investigated.
Previously reported susceptibility loci for suicide attempt in BD were also investigated. Associations
were tested by logistic regression with Bonferroni correction for multiple testing.
Results: The risk allele in rs2239547 (ITIH3/4-region) was signiﬁcantly associated with a history of
suicide attempt (p¼0.01) after multiple testing correction (p thresholdo0.017). The previous suicide
attempt susceptibility loci were only nominally associated, but had the same direction of risk in the
replication sample (sign test, p¼0.02).
Limitations: Relatively small sample size and retrospective clinical assessment.
Conclusions: We detected a novel association between suicide attempt and the ITIH3/4-region in
a combined group of patients with BD, SCZ and related psychosis spectrum disorders. This may be
useful in understanding molecular mechanisms of suicidal behaviour in severe mental disorders,
although replication is warranted.
& 2014 The Authors. Published by Elsevier B.V.
1. Introduction
Patients with bipolar disorder (BD) and schizophrenia (SCZ)
have several overlapping clinical characteristics including suicide
that causes excess mortality with a large impact on early death
(Nordentoft et al., 2013). Both BD and SCZ are understood in
relation to diagnostic spectrums (Ivleva et al., 2008), and there is a
growing body of evidence supporting that clinical and genetic risk
factors are shared (Hamshere et al., 2011; Lichtenstein et al., 2009).
BD, SCZ and suicidal behaviour (SB) are all inﬂuenced by genetic
factors (Baldessarini and Hennen, 2004; Roy et al., 1999). Never-
theless, it remains unclear whether the association between SB
and these disorders is due to shared genetic risk factors (Brent and
Mann, 2005; Goodwin and Jamison, 2007; Qin et al., 2002;
Schizophrenia Psychiatric GWAS Consortium, 2011), thus warrant-
ing studies investigating if BD and SCZ risk genes also predispose
to SB (Baldessarini and Hennen, 2004; McGufﬁn et al., 2010).
Large genome-wide association studies (GWAS) on BD and SCZ
have provided promising results on common genetic risk factors
(Andreassen et al., 2013; Psychiatric GWAS Consortium Bipolar
Disorder Working Group, 2011; Schizophrenia Psychiatric GWAS
Consortium, 2011). Despite these recent ﬁndings, each genetic
locus has a small effect size, and much unexplained variance
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(‘missing heritability’) remains. SB may be a sub-phenotype that
reﬂects more genetic homogeneity beyond diagnostic categories of
neuropsychiatric disorders (Craddock and Sklar, 2009). A molecu-
lar genetic relationship between SB and BD and SCZ may lead to
new insight in biological pathways of the disorders, thereby
forming a basis for improved prediction and thus prevention.
To our knowledge, only two studies have performed GWAS on SB
in patients with BD (Perlis et al., 2010;Willour et al., 2012) and none in
patients with SCZ. Several candidate susceptibility loci were identiﬁed
but no common genetic variants of any large effect. The low odds
ratios and the lack of signiﬁcant ﬁndings suggest a high level of
polygenicity in the genetic risk of SB in BD.
Recently, a large joint GWAS of BD and SCZ identiﬁed three
signiﬁcant risk loci for BD and SCZ, located in ANK3, CACNA1C and
the ITIH3/4-region (Schizophrenia Psychiatric GWAS Consortium,
2011). CACNA1C and ANK3 have previously been found to be
associated with both SCZ and BD (Athanasiu et al., 2010; Ferreira
et al., 2008; Psychiatric GWAS Consortium Bipolar Disorder
Working Group, 2011). Since SB is prevalent in SCZ and BD, these
disease risk genes may also be associated with SB in these disorders.
This study uses a sample of patients with BD, SCZ and related
psychosis spectrum disorders to (1) test for association between
joint BD and SCZ risk variant SNPs and SB (Schizophrenia
Psychiatric GWAS Consortium, 2011) testing the hypothesis that
these SNPs are associated to higher risk of patient suicide attempt,
and (2) replicate SB susceptibility loci SNPs previously identiﬁed in
BD cases (Perlis et al., 2010; Willour et al., 2012) testing the
hypothesis that these susceptibility loci SNPs for SB in BD would
be replicated in our combined sample, since a high fraction of the
genetic risk of BD, SCZ and related psychosis spectrum disorders is
shared (Andreassen et al., 2013).
2. Methods
2.1. Sample
A total number of 1009 psychiatric patients (526 BD cases, 338
SCZ cases and 145 cases with related psychosis spectrum disorders
(MIXED)) were included (Table 1). The terms BD, SCZ and MIXED
are used to deﬁne these groups. All were of European, the majority
Norwegian, ethnicity recruited from several Norwegian hospitals
and out-patient clinics. All patients met DSM-IV criteria for their
respective diagnosis using the Structured Clinical Interview for
DSM-IV (SCID-I) (American Psychiatric Association, 1994; First
et al., 1997).
2.2. Ethics
Written, informed consent was obtained from all participants.
The Regional Committees for Research Ethics and the Norwegian
Data Inspectorate approved the study.
2.3. Clinical assessment
Diagnostic evaluation was performed by trained senior psy-
chiatrists and psychologists. All patients participated in semi-
structured interviews with trained clinicians, which included
life-time history of at least one suicide attempt. Based on these
data the patients were grouped dichotomously; suicide attempters
and non-attempters. Clinical risk factors of SB in the sample have
been described in detail previously (Finseth et al., 2012; Mork
et al., 2012).
2.4. Genotyping and imputation
The sample was genotyped using the Affymetrix Genome-Wide
Human SNP array 6.0 (Affymetrix Inc, Santa Clara, CA, USA).
Quality control was performed using PLINK (Purcell et al., 2007).
Individuals with genotyping below 95% were excluded, as were
SNPs with minor allele frequency (MAF)o1%, low yield (o95%)
and deviation from Hardy–Weinberg equilibrium (po0.001).
Candidate SNPs and SB susceptibility SNPs not present on the
Affymetrix Genome-Wide Human SNP array 6.0 were imputed
with MACH that applies a Markov Chain Haplotyping algorithm (Li
et al., 2010), using the European samples available in the Phase I
release of the 1000 genomes project (http://www.sph.umich.edu/
csg/abecasis/MACH/download/1000G-PhaseI-Interim.html) after
quality control. For further description on genotyping and imputa-
tion procedures, see Supplementary Material.
2.5. Choice of joint BD and SCZ risk variant SNPs
In the primary analysis, the three top SNP hits from the largest
joint GWAS on BD and SCZ to date were included (Schizophrenia
Psychiatric GWAS Consortium, 2011) as deﬁned by the conserva-
tive inclusion criterion of p-values meeting genome-wide signiﬁ-
cance (cut-off o5108) (Table 2). In the secondary analysis,
Table 1
Demographics of suicide attempters vs. non-attempters.
Total Suicide attempters Non-attempters w2/z df p-value
N % N % N %
Total 1009 100 338 33.5 671 66.5
Diagnostic groupa 1.43 2 0.489
BDb 526 52.1 185 35.2 341 64.8
SCZc 338 33.5 106 31.4 232 68.6
MIXEDd 145 14.4 47 32.4 98 67.6
Gendera 12.5 1 o0.0001
Female 518 48.7 200 38.6 318 61.4
Male 491 51.3 138 28.1 353 71.9
Duration of illness, years (mean7SD)e 16.8 712.5 12.8 711.7 5.4 o0.0001
Abbreviations: df—degrees of freedom, SD—standard deviation.
a Chi-square test.
b BD I: 304 cases, BD II: 197 cases and BD NOS: 25 cases.
c Schizophrenia: 258 cases, Schizophreniform disorder: 24 cases and Schizoaffective disorder: 56 cases.
d Related BD and SCZ spectrum disorders: Other psychosis: 94 cases and Major depressive disorder: 51 cases.
e Mann–Whitney test.
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SNPs from the Affymetrix Genome-Wide Human SNP Array
6.0 within ANK3, CACNA1C and the ITIH3/4-region by extracting
SNPs based on UCSC coordinates 720 kb (hg19) (ANK3 and
CACNA1C) and from the ITIH3/4 gene region based on the candi-
date SNP7250 kb were analyzed (Supplementary Table 1).
2.6. Choice of SB susceptibility loci SNPs
In the replication of the two previous GWAS on suicide attempt
in patients with BD, we included SNPs obtaining p-values below
0.001 with MAF 40.01 in the primary analysis of the studies on
BD samples, respectively 2468 SNPs SNPs (Willour et al., 2012) and
2092 SNPs (Perlis et al., 2010) (Supplementary Table 2).
2.7. Statistical analysis
Explorative analyses of associations between suicide attempt
and gender, diagnosis and duration of illness were performed
using the Statistical Package for the Social Sciences (SPSS Statis-
tics) version 17.0 (SPSS Inc., Chicago, IL, USA) to identify possible
confounders to be included in the association analysis between
suicide attempt and SNPs. Associations between SNPs and suicide
attempt (dichotomous: yes/no) were tested through the additive
model of logistic regression in PLINK. Using the genetic power
calculator CATS (http://www.sph.umich.edu/csg/abecasis/CaTS/)
our combined SCZ/BD/MIXED sample was estimated to have 63%
power to detect a locus at a p-value of 0.001 for a minor allele
frequency of 0.3 and a genotypic relative risk of 1.5. Sign tests were
performed with the binomial test in R as done previously
(Schizophrenia Psychiatric GWAS Consortium, 2011).
2.8. Correction for multiple testing
In the primary analysis, Bonferroni correction threshold for
three independent SNPs was set at po0.017 (0.05/3 SNPs). In the
secondary extended SNP analysis within the genes (509 Affymetrix
SNPs), the number of independent SNPs was deﬁned by LD blocks
(139) determined by conﬁdence bounds on the normalized mea-
sure of allelic association (D0) (Supplementary Table 1). Thus,
threshold for signiﬁcance was set at po3.6104 (0.05/
139 SNPs).
In the replication of suicide attempt susceptibility loci SNPs, the
Bonferroni correction was set at po1.1105 (0.05/4562 SNPs).
3. Results
3.1. Diagnosis and demographics
The three diagnostic groups, SCZ, BD and MIXED, did not differ
signiﬁcantly from each other with regard to history of suicide
attempt (p¼0.489). The suicide attempt rate was signiﬁcantly
higher in women than in men (po0.0001), and suicide attempters
had a longer duration of illness than non-attempters (po0.0001)
(Table 1). Thus, both gender and duration of illness were included
as covariates in the following regression models.
3.2. Risk variant SNPs of BD and SCZ vs. SB sub-phenotype
In the primary analysis, rs2239547 (the ITIH3/4-region) was
signiﬁcantly associated with suicide attempt after Bonferroni
correction (nominal p¼0.01) (Table 2). None of the SNPs were
signiﬁcantly associated with suicide attempt within the SCZ/BD,
SCZ or BD subsamples (Table 2).
In the secondary analysis, 36 SNPs had a nominally signiﬁcant
level of association with suicide attempt (po0.05) in the SCZ/BD/
MIXED sample, the lowest being p¼0.0021 (rs12251392)
(Supplementary Table 3). None of these SNPs remained signiﬁcant
after Bonferroni correction for multiple testing.
These markers were originally identiﬁed in patients with SCZ
and BD. However, even though 36 SNPs were nominally associated
with suicide attempt (po0.05), the lowest being p¼0.0063
(rs12251392) (n¼820–863) (Supplementary Table 3) within the
SCZ/BD group alone excluding the extended spectrum of related
disorders, none of these SNPs remained signiﬁcant after Bonfer-
roni correction.
3.3. Susceptibility loci SNPs of SB vs. SB sub-phenotype
None of these SNPs remained signiﬁcant after Bonferroni
correction for multiple testing (Supplementary Table 4). The
sample produced odds ratios in the same direction as the original
studies more frequently than expected by chance. 64 of 106
independent SNPs with po0.0001 from the original studies
showed a same-direction allelic association in our replication
sample (sign test, p¼0.02), as did the isolated replication of the
Perlis et al. (2010) study, with 28 of 44 SNPs going in the same
direction (sign test, p¼0.048) (Supplementary Table 5).
The suicide attempt candidate SNPs were originally identiﬁed
in isolated BD samples. However, none of the SNPs were signiﬁ-
cant after Bonferroni correction (Supplementary Table 4) in the BD
group alone (n¼526), nor was there evidence of aggregated same-
direction allelic association (sign test, p40.05) (Supplementary
Table 5).
4. Discussion
The most important ﬁnding in this study was a signiﬁcant
association after multiple testing corrections between a SNP in the
ITIH3/4-region and suicide attempt in severe mental disorders.
This result indicates that some of the SB sub-phenotype in patients
with BD, SCZ and related psychosis spectrum disorders may be
accounted for by genetic variation at the ITIH3/4-region, one of the
strongest supported candidate gene regions for SCZ and BD
(Psychiatric GWAS Consortium Bipolar Disorder Working Group,
2011; Schizophrenia Psychiatric GWAS Consortium, 2011).
Table 2
Association between schizophrenia/bipolar disorder top hit risk variant SNPs and suicide attempt.
SNP CHR BP Gene A1 Suicide attempt, SCZ/BD/MIXED Suicide attempt, SCZ/BD Suicide attempt, BD Suicide attempt, SCZ
N¼1009 (338 cases) N¼864 (292 cases) N¼526 (185 cases) N¼338 (106 cases)
FRQ OR p-value FRQ OR p-value FRQ OR p-value FRQ OR p-value
rs2239547 3 52855229 ITIH3/4-region T 0.75 1.35 0.01 0.75 1.31 0.03 0.77 1.29 0.11 0.72 1.37 0.13
rs10994359 10 62222107 ANK3 T 0.93 1.02 0.90 0.93 1.01 0.98 0.93 1.16 0.56 0.94 0.76 0.42
rs4765905 12 2349584 CACNA1C G 0.64 1.14 0.21 0.64 1.17 0.17 0.65 1.14 0.34 0.62 1.23 0.27
Abbreviations: SNP—single nucleotide polymorphism; CHR—chromosome; BP—base pair; A1—risk allele; FRQ—frequency; OR—odds ratio.
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The underlying mechanism of the association between the
ITIH3/4-region and SB in these psychiatric disorders is unknown.
ITIH3 is expressed both in liver and brain, while ITIH4 is only
expressed in liver (Daveau et al., 1998). The ITIH3/4-associated SNP
is in perfect LD with a coding variant in ITIH4 (rs4687657)
(Schizophrenia Psychiatric GWAS Consortium, 2011). The ITIH
proteins are involved in the inﬂammatory acute phase response
(Bost et al., 1998; Hamm et al., 2008), and the ITIH4 protein has
been suggested as a biomarker of neuroinﬂammation (Kashyap
et al., 2009; Yang et al., 2012) but a possible involvement of the
inﬂammatory function of the ITIH proteins in SB is yet to be
investigated. Interestingly, epidemiological studies show correla-
tion between allergic inﬂammation and suicide (Qin et al., 2013).
Another study also linking the immune system with SB showed
that a polymorphism in the gene regulating the acute phase
reactant C-reactive protein was associated with both impulsive-
ness and SB (Suchankova et al., 2013). The involvement of
neuroinﬂammation in BD and SCZ is already well documented
(Najjar et al., 2013; Stefansson et al., 2009) but further studies
are warranted to explore a possible similar underlying mechanism
in SB.
We did not ﬁnd any evidence supporting associations between
suicide attempt and ANK3 and CACNA1C, suggesting that these
other two candidate genes of BD and SCZ are less involved in the
genetic risk of SB in patients with BD and SCZ.
We were not able to replicate the results for any of the
previously identiﬁed susceptibility loci for suicide attempt in BD,
originating from two GWA-studies (Perlis et al., 2010; Willour
et al., 2012). Failure to replicate previous results of suicide attempt
susceptibility loci SNPs suggests that the heritability of the suicide
attempt sub-phenotype is not due to large effects of any of these
susceptibility loci. However, the signiﬁcant result of the sign test
indicated that an aggregate of these SNPs was in alignment with
the original studies more often than would be expected by chance.
This suggests a polygenic model with additive effects of several
risk alleles to SB. Thus, these gene variants might be found
signiﬁcantly associated in larger studies with adequate power.
4.1. Strengths and limitations
The strength of this study is the sample of representative
psychiatric patients from all social classes receiving standard
clinical treatment with a common platform for study inclusion
from the ethnically homogenous Norwegian population.
The sample size limited the power to replicate true suscept-
ibility loci of SB. The complex SB trait with polygenic risk factors
and the retrospective assessment of SB may have resulted in
underestimation of suicide attempts due to recall bias. Also,
patients who committed suicide before a possible inclusion to
the study might have had a different and perhaps stronger genetic
risk of SB than those who were included here. Suicidal ideation
could be closer related to the familial transmission of psychiatric
disease liability (Brent et al., 1996) and future studies with the
ability to differentiate results between impulsivity, suicidal idea-
tion, suicide attempt and committed suicide, would elucidate this
further.
4.2. Conclusion
We detected a novel association between a SNP in the ITIH3/4-
region and suicide in a combined group of patients with BD, SCZ
and related disorders in the psychosis spectrum. This warrants
further replication attempts, preferably in larger samples, and may
be useful in understanding molecular mechanisms of SB in severe
mental disorders.
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